Mj Galindo - Unidad Enfermedades Infecciosas, Hospital Clínico Universitario. Valencia

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial

Carmen Hidalgo Tenorio, Sergio Sequera, María J. Vivancos,David Vinuesa,Antonio Collado,Ignacio De Los Santos, Patricia Sorni, Noemi Cabello-Clotet,Marta Montero, Carlos Ramos Font,Alberto Terron,MJ Galindo,

International Journal of Antimicrobial Agentsno. 6 (2024): 107164-107164

引用0浏览0WOS引用

Real-life data of bictegravir/ emtricitabine/tenofovir alafenamide in virologically suppressed adults living with VIH-1. 48-96 weeks results of RETROBIC study

J. Troya, R. Mican, G. Pousada, C. Galera, J. Sanz, I. Santos, C. Duenas,N. Cabello, C. Martin,M. J. Galindo, M. A. Garcinuno, C. Hernandez,

HIV MEDICINE (2023): 88-89

引用0浏览0引用

A pre-post experimental study to assess the usefulness and feasibility of collecting routinely patient-reported outcomes in clinical practice (PROCARE)

C. Iniesta, C. Prats-Silvestre,M. J. Galindo, A. Ferrer, J. C. Lopez, L. Perez, J. A. Perez-Molina, B. Gullon-Pena, A. Rivero, L. Bailon, J. Puig, C. Miranda,

HIV MEDICINE (2023): 235-235

引用0浏览0引用

New risk factors for fragility fractures must be considered in older adults with HIV

F. Branas, J. Vergas, M. Ramirez, P. Ryan, F. Dronda,M. J. Galindo, M. Torralba, A. Antela, A. Cabello, M. L. Montes, I. Machuca, M. J. Bustinduy,

HIV MEDICINE (2023): 264-265

引用0浏览0引用

Real-life data of bictegravir/ emtricitabine/tenofovir alafenamide in virologically suppressed women with VIH-1

G. Pousada, L. Buzon, J. Troya, R. Mican, C. Galera, I. Santos, J. Sanz, C. Martin, M. A. Garcinuno,M. J. Galindo,N. Cabello, R. Pedrero-Tome,

HIV MEDICINE (2023): 93-94

引用0浏览0引用

Dual therapy with DTG+3TC or DTG+RPV versus triple therapy with B/F/TAF in virologically suppressed adults living with HIV-1: Ummunological outcomes in real-life experience

J. Troya, L. Buzon, G. Pousada, R. Mican, C. Galera, J. Sanz, I. Santos, C. Duenas,N. Cabello, C. Martin,M. J. Galindo, M. A. Garcinuno,

HIV MEDICINE (2023): 91-92

引用0浏览0引用

Bictegravir/Emtricitavine/ Tenofovir alafenamide as first-line treatment in naive HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial

C. Hidalgo-Tenorio, S. Sequera, A. Collado, D. Vinuesa, M. J. Vivancos,I. De Los Santos, P. Sorni,N. Cabello, M. Montero, A. Terron, O. Martinez, M. Omar-Mohamed,

HIV MEDICINE (2023): 212-212

引用0浏览0引用

Weight and Body mass index gain among people living with HIV-1 switching to a single tablet of bictegravir /emtricitabine/tenofovir alafenamide